Gaudium IVF IPO Day 1: Subscribes 40%, GMP, brokerage views, and key details

Gaudium IVF and Women Health IPO opened with nearly 40% subscription on Day 1, driven by strong retail demand. GMP संकेत moderate listing gains. Brokerages recommend subscribing, citing growth potential in India’s fertility services market, though valuation concerns and a pending tax dispute remain key risks for investors to monitor.